Gamma Investing LLC Ardelyx, Inc. Transaction History
Gamma Investing LLC
- $734 Billion
- Q2 2024
A detailed history of Gamma Investing LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Gamma Investing LLC holds 101 shares of ARDX stock, worth $649. This represents 0.0% of its overall portfolio holdings.
Number of Shares
101
Previous 662
84.74%
Holding current value
$649
Previous $4.83 Million
84.52%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARDX
# of Institutions
209Shares Held
144MCall Options Held
1.01MPut Options Held
1.43M-
Janus Henderson Group PLC London, X025.9MShares$167 Million0.11% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$113 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.7MShares$87.8 Million0.0% of portfolio
-
State Street Corp Boston, MA12MShares$76.9 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C36.9MShares$44.4 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $994M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...